Needle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research
11. November 2024 11:59 ET
|
Dimension Market Research
New York, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Needle Free Injectors Market is projected to grow from USD 1,478.9 Million in 2024 to USD 2,980.9 Million by 2033, at a CAGR...
Unity Consortium Marks Adolescent Immunization Action Week (AIAW) with activities to help Parents and Adolescents get up to date on Recommended Vaccines
28. März 2024 08:05 ET
|
Unity Consortium
Unity Consortium marks Adolescent Immunization Action Week, April 1-5, 2024, encouraging parents and adolescents to get up to date on recommended vaccines
New Video Series Arms Texas Educators and Health Professionals With Resources About Vaccine Efficacy
24. Januar 2024 07:00 ET
|
The Immunization Partnership
Houston, TX, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Immunization Partnership (TIP), a statewide nonprofit committed to a healthy Texas, is working to help Texas school and health officials educate...
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca
12. Dezember 2023 02:05 ET
|
Icosavax, Inc.
Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
12. Dezember 2023 02:00 ET
|
Icosavax, Inc.
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14. August 2023 16:05 ET
|
Icosavax, Inc.
- Positive topline interim Phase 1 results for bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults - - Positive twelve-month immunogenicity data and initial proof-of-concept...
Hypodermic Needles Market revenue to cross USD 9 Billion by 2035, says Research Nester
08. August 2023 07:00 ET
|
Research Nester
New York, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global hypodermic needles market size is projected to grow at a CAGR of over ~4% from 2023 to 2035. The market is expected to garner a revenue of USD...
Prevention and Immunization, the Key to Achieve a More Efficient Healthcare System Worldwide
03. Juli 2023 07:14 ET
|
Fundación Bamberg
BERLIN, July 03, 2023 (GLOBE NEWSWIRE) -- The Bamberg Foundation, together with key stakeholders from the healthcare and public sectors, gathered in Berlin to discuss the strategic priorities that...
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
27. Juni 2023 07:00 ET
|
AC Immune SA
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease Ongoing Phase 1b/2 ABATE study enrolling well and expanding to sites...
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
12. April 2023 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...